Background Safer opioid supply programs provide prescription pharmaceutical opioids,
often with supportive services, to people at high risk of experiencing harms related to …

Background Historical restrictions on take-home medications for opioid use disorder have
generated considerable debate. The COVID-19 pandemic shifted the perceived risks and …

Background Canada is experiencing an unprecedented drug toxicity crisis driven by a highly
toxic unregulated drug supply contaminated with fentanyl, benzodiazepine, and other drugs …

Background During a COVID-19 outbreak in the congregate shelter system in Halifax, Nova
Scotia, Canada, a healthcare team provided an emergency “safe supply” of medications and …

Objectives Fentanyl has contributed to a sharp rise in the toxicity of the unregulated drug
supply and fatal overdoses in Canada. It has also changed injection practices. Injection …

Abstract Background Within North America and worldwide, drug-related overdoses have
increased dramatically over the past decade. COVID-19 escalated the need for a safer …

Background As the overdose crisis in Canada continues to escalate in severity, novel
interventions and programs are required. Safer Supply programs offer pharmaceutical-grade …

Background Novel public health interventions are needed to address the toxic drug supply
and meet the needs of people who use drugs amidst the overdose crisis. Safer supply–low …

Introduction The ongoing opioid overdose crisis, which has killed over 30,000 people in
Canada since 2016, is driven by the volatility of an unregulated opioid drug supply …

Abstract The 2000–2001 and the 2022–2023 Taliban opium bans were and could be two of
the largest ever disruptions to a major illegal drug market. To help understand potential …